Ekambar R. Kandimalla

Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

Dan C. McManus, Charles Lefebvre, Gabriele Cherton-Horvat et al. · Oncogene · 2004 · 170 citations

Life Sciences, Molecular Biology, Oncology +12

Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 Increases Neovascularization and Blood Flow Recovery After Ischemia

S. Welten, A.J.N.M. Bastiaansen, Rob C. M. de Jong et al. · Circulation Research · 2014 · 142 citations

Medicine, Biomedical Sciences, Molecular Medicine +16

Preclinical Characterization of AEG35156/GEM 640, a Second-Generation Antisense Oligonucleotide Targeting X-Linked Inhibitor of Apoptosis

Eric C. LaCasse, Gabriele Cherton-Horvat, Kimberley E. Hewitt et al. · Clinical Cancer Research · 2006 · 129 citations

Medicine, Oncology, Pharmacology +17

Survivin inhibition induces human neural tumor cell death through caspase‐independent and ‐dependent pathways

Sai Latha Shankar, Sridhar Mani, Kathleen O’Guin et al. · Journal of Neurochemistry · 2001 · 109 citations

Medicine, Cell Biology, Oncology +14

Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent Toll-like receptor 9 agonists

Ekambar R. Kandimalla, Lakshmi Bhagat, Yukui Li et al. · Proceedings of the National Academy of Sciences · 2005 · 97 citations

Life Sciences, Immunology, Molecular Biology +17